vs

Side-by-side financial comparison of GRAHAM CORP (GHM) and PROCEPT BioRobotics Corp (PRCT). Click either name above to swap in a different company.

PROCEPT BioRobotics Corp is the larger business by last-quarter revenue ($83.1M vs $56.7M, roughly 1.5× GRAHAM CORP). GRAHAM CORP runs the higher net margin — 5.0% vs -38.1%, a 43.1% gap on every dollar of revenue. On growth, GRAHAM CORP posted the faster year-over-year revenue change (20.5% vs 20.2%). Over the past eight quarters, PROCEPT BioRobotics Corp's revenue compounded faster (24.8% CAGR vs 7.5%).

Graham Holdings Company is a diversified American conglomerate holding company. Headquartered in Arlington County, Virginia, and incorporated in Delaware, it was formerly the owner of The Washington Post newspaper and Newsweek magazine.

PROCEPT BioRobotics Corp is a medical tech firm developing and commercializing robotic surgical solutions for urological care. Its flagship AquaBeam system provides image-guided minimally invasive therapy for benign prostatic hyperplasia, serving providers and patients across North America, Europe and global markets.

GHM vs PRCT — Head-to-Head

Bigger by revenue
PRCT
PRCT
1.5× larger
PRCT
$83.1M
$56.7M
GHM
Growing faster (revenue YoY)
GHM
GHM
+0.3% gap
GHM
20.5%
20.2%
PRCT
Higher net margin
GHM
GHM
43.1% more per $
GHM
5.0%
-38.1%
PRCT
Faster 2-yr revenue CAGR
PRCT
PRCT
Annualised
PRCT
24.8%
7.5%
GHM

Income Statement — Q3 FY2026 vs Q1 FY2026

Metric
GHM
GHM
PRCT
PRCT
Revenue
$56.7M
$83.1M
Net Profit
$2.8M
$-31.6M
Gross Margin
23.8%
64.9%
Operating Margin
5.5%
-4.1%
Net Margin
5.0%
-38.1%
Revenue YoY
20.5%
20.2%
Net Profit YoY
79.2%
-27.9%
EPS (diluted)
$0.25
$-0.56

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
GHM
GHM
PRCT
PRCT
Q1 26
$83.1M
Q4 25
$56.7M
$76.4M
Q3 25
$66.0M
$83.3M
Q2 25
$55.5M
$79.2M
Q1 25
$59.3M
$69.2M
Q4 24
$47.0M
$68.2M
Q3 24
$53.6M
$58.4M
Q2 24
$50.0M
$53.4M
Net Profit
GHM
GHM
PRCT
PRCT
Q1 26
$-31.6M
Q4 25
$2.8M
$-29.8M
Q3 25
$3.1M
$-21.4M
Q2 25
$4.6M
$-19.6M
Q1 25
$4.4M
$-24.7M
Q4 24
$1.6M
$-18.9M
Q3 24
$3.3M
$-21.0M
Q2 24
$3.0M
$-25.6M
Gross Margin
GHM
GHM
PRCT
PRCT
Q1 26
64.9%
Q4 25
23.8%
60.6%
Q3 25
21.7%
64.8%
Q2 25
26.5%
65.4%
Q1 25
27.0%
63.9%
Q4 24
24.8%
64.0%
Q3 24
23.9%
63.2%
Q2 24
24.8%
59.0%
Operating Margin
GHM
GHM
PRCT
PRCT
Q1 26
-4.1%
Q4 25
5.5%
-40.6%
Q3 25
6.5%
-27.8%
Q2 25
8.9%
-28.0%
Q1 25
9.3%
-39.7%
Q4 24
4.7%
-28.9%
Q3 24
7.9%
-38.4%
Q2 24
6.5%
-50.3%
Net Margin
GHM
GHM
PRCT
PRCT
Q1 26
-38.1%
Q4 25
5.0%
-39.1%
Q3 25
4.7%
-25.7%
Q2 25
8.3%
-24.7%
Q1 25
7.4%
-35.8%
Q4 24
3.4%
-27.6%
Q3 24
6.1%
-35.9%
Q2 24
5.9%
-48.0%
EPS (diluted)
GHM
GHM
PRCT
PRCT
Q1 26
$-0.56
Q4 25
$0.25
$-0.54
Q3 25
$0.28
$-0.38
Q2 25
$0.42
$-0.35
Q1 25
$0.40
$-0.45
Q4 24
$0.14
$-0.34
Q3 24
$0.30
$-0.40
Q2 24
$0.27
$-0.50

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
GHM
GHM
PRCT
PRCT
Cash + ST InvestmentsLiquidity on hand
$22.3M
$245.6M
Total DebtLower is stronger
$51.7M
Stockholders' EquityBook value
$131.3M
$347.7M
Total Assets
$292.9M
$487.1M
Debt / EquityLower = less leverage
0.15×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
GHM
GHM
PRCT
PRCT
Q1 26
$245.6M
Q4 25
$22.3M
$286.5M
Q3 25
$20.6M
$294.3M
Q2 25
$10.8M
$302.7M
Q1 25
$21.6M
$316.2M
Q4 24
$30.0M
$333.7M
Q3 24
$32.3M
$196.8M
Q2 24
$21.6M
$214.1M
Total Debt
GHM
GHM
PRCT
PRCT
Q1 26
$51.7M
Q4 25
$51.6M
Q3 25
$51.6M
Q2 25
$51.5M
Q1 25
$51.5M
Q4 24
$51.5M
Q3 24
$51.4M
Q2 24
$51.4M
Stockholders' Equity
GHM
GHM
PRCT
PRCT
Q1 26
$347.7M
Q4 25
$131.3M
$365.9M
Q3 25
$127.6M
$380.3M
Q2 25
$123.4M
$385.8M
Q1 25
$119.6M
$389.2M
Q4 24
$114.4M
$402.2M
Q3 24
$112.5M
$241.2M
Q2 24
$108.2M
$251.8M
Total Assets
GHM
GHM
PRCT
PRCT
Q1 26
$487.1M
Q4 25
$292.9M
$508.1M
Q3 25
$287.0M
$511.5M
Q2 25
$252.3M
$513.1M
Q1 25
$264.1M
$519.4M
Q4 24
$264.3M
$534.0M
Q3 24
$249.5M
$374.1M
Q2 24
$244.2M
$374.4M
Debt / Equity
GHM
GHM
PRCT
PRCT
Q1 26
0.15×
Q4 25
0.14×
Q3 25
0.14×
Q2 25
0.13×
Q1 25
0.13×
Q4 24
0.13×
Q3 24
0.21×
Q2 24
0.20×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
GHM
GHM
PRCT
PRCT
Operating Cash FlowLast quarter
$4.8M
Free Cash FlowOCF − Capex
$2.4M
FCF MarginFCF / Revenue
4.3%
Capex IntensityCapex / Revenue
4.1%
Cash ConversionOCF / Net Profit
1.67×
TTM Free Cash FlowTrailing 4 quarters
$-6.1M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
GHM
GHM
PRCT
PRCT
Q1 26
Q4 25
$4.8M
$-10.3M
Q3 25
$13.6M
$-6.6M
Q2 25
$-2.3M
$-15.0M
Q1 25
$-3.6M
$-17.0M
Q4 24
$5.2M
$-32.4M
Q3 24
$13.9M
$-18.8M
Q2 24
$8.7M
$-15.7M
Free Cash Flow
GHM
GHM
PRCT
PRCT
Q1 26
Q4 25
$2.4M
$-12.2M
Q3 25
$9.4M
$-9.5M
Q2 25
$-9.3M
$-17.8M
Q1 25
$-8.7M
$-18.8M
Q4 24
$-2.1M
$-33.6M
Q3 24
$10.4M
$-19.0M
Q2 24
$5.7M
$-16.8M
FCF Margin
GHM
GHM
PRCT
PRCT
Q1 26
Q4 25
4.3%
-15.9%
Q3 25
14.3%
-11.4%
Q2 25
-16.7%
-22.5%
Q1 25
-14.7%
-27.2%
Q4 24
-4.5%
-49.2%
Q3 24
19.5%
-32.6%
Q2 24
11.5%
-31.4%
Capex Intensity
GHM
GHM
PRCT
PRCT
Q1 26
Q4 25
4.1%
2.4%
Q3 25
6.3%
3.4%
Q2 25
12.6%
3.5%
Q1 25
8.7%
2.7%
Q4 24
15.6%
1.7%
Q3 24
6.5%
0.4%
Q2 24
6.0%
2.0%
Cash Conversion
GHM
GHM
PRCT
PRCT
Q1 26
Q4 25
1.67×
Q3 25
4.40×
Q2 25
-0.49×
Q1 25
-0.81×
Q4 24
3.29×
Q3 24
4.25×
Q2 24
2.94×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

GHM
GHM

Defense$35.3M62%
Energy And Process$18.3M32%
Space$3.1M6%

PRCT
PRCT

Handpieces and other consumables$43.0M52%
System sales and rentals$23.4M28%
Other$11.1M13%
Service$5.6M7%

Related Comparisons